The utility of the combination of a SPECT study with [123I]--FP--CIT of dopamine transporters and [123I]--MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes, Nucl Med Commun. juin, vol.38, issue.6, pp.487-92, 2017. ,
Potential diagnostic value of regional myocardial adrenergic imaging using (123)I--MIBG SPECT to identify patients with Lewy body diseases, Eur J Nucl Med Mol Imaging. juin, vol.42, issue.7, pp.1043-51, 2015. ,
Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease, Parkinsons Dis, p.295346, 2010. ,
Profound cardiac sympathetic denervation occurs in Parkinson disease, Brain Pathol. janv, vol.15, issue.1, pp.29-34, 2005. ,
Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I--metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses, BMC Neurol. 15 mai, vol.15, p.83, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02052612
Proposal for standardization of 123I--metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology, Eur J Nucl Med Mol Imaging. août, vol.37, issue.9, pp.1802-1814, 2010. ,
Performance of a semiconductor SPECT system: comparison with a conventional Anger--type SPECT instrument, Ann Nucl Med. janv, vol.27, issue.1, pp.11-17, 2013. ,
First assessment of simultaneous dual isotope (123I/99mTc) cardiac SPECT on two different CZT cameras: A phantom study, J Nucl Cardiol. oct, vol.25, issue.5, pp.1692-704, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01777803
First determination of the heart--to--mediastinum ratio using cardiac dual isotope ( 123 I--MIBG/ 99 mTc--tetrofosmin) CZT imaging in patients with heart failure: the ADRECARD study, Eur J Nucl Med Mol Imaging, vol.42, issue.12, pp.1912-1921, 2015. ,
Determination of the Heart--to--Mediastinum Ratio of 123I--MIBG Uptake Using Dual--Isotope (123I--MIBG/99mTc--Tetrofosmin) Multipinhole Cadmium--Zinc--Telluride SPECT in Patients with Heart Failure, J Nucl Med. févr, vol.59, issue.2, pp.251-259, 2018. ,
A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta--iodobenzylguanidine (MIBG), Nucl Med Commun. juill, vol.13, issue.7, pp.513-534, 1992. ,
Cardiac 123I--MIBG scintigraphy in patients with drug induced parkinsonism, J Neurol Neurosurg Psychiatry. mars, vol.77, issue.3, pp.372-376, 2006. ,
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium, Neurology, vol.89, issue.1, pp.88-100, 2017. ,
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria, Mov Disord, vol.32, issue.6, pp.853-64, 2017. ,
MDS clinical diagnostic criteria for Parkinson's disease, Mov Disord, vol.30, issue.12, pp.1591-601, 2015. ,
Criteria for the diagnosis of corticobasal degeneration, Neurology. 29 janv, vol.80, issue.5, pp.496-503, 2013. ,
Second consensus statement on the diagnosis of multiple system atrophy, Neurology. 26 août, vol.71, issue.9, pp.670-676, 2008. ,
Left ventricular function assessment using 123I/99mTc dual--isotope acquisition with two semi--conductor cadmium--zinc--telluride (CZT) cameras: a gated cardiac phantom study, EJNMMI Phys. déc, vol.3, issue.1, p.27, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01815107
Statistical methods for assessing agreement between two methods of clinical measurement, Lancet. 8 févr, vol.1, issue.8476, pp.307-317, 1986. ,
Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG, J Nucl Med. janv, vol.41, issue.1, pp.71-78, 2000. ,
Myocardial iodine--labeled metaiodobenzylguanidine 123 uptake relates to age, J Nucl Cardiol. avr, vol.2, issue.2, pp.126-158, 1995. ,